Ghana vs Namibia: Cause of death, by non-communicable diseases, ages 0-4, male
Ghana
11.8%
in 2021
Namibia
11.6%
in 2021
Ghana rank
140th
Namibia rank
142nd
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Ghana
- Namibia
How they compare
Ghana currently reports 11.8% against 11.6% in Namibia, a difference of 0.2%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Namibia ahead.
Ghana ranks 140th and Namibia ranks 142nd of 185 countries.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.1% | 5.6% | 0.5% | Namibia |
| 2010s | 9.2% | 10.1% | 0.8% | Namibia |
| 2020s | 11.6% | 11.6% | 0.0% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Ghana or Namibia?
- Ghana, at 11.8% against 11.6% in Namibia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Ghana and Namibia?
- 0.2%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Namibia?
- 6 years are reported by both, from 2000 to 2021.
- How do Ghana and Namibia rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Ghana ranks 140th and Namibia ranks 142nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.